COVID-19 virus pandemic is reaching its peak in Europe after first reported at Wuhan province in China about 6 months ago. It has been associated with many different presentations, signs and symptoms affecting the skin. However, this report is first to confirm the direct link between the virus and flare up of moderate-severe psoriasis. Further observations will be needed in order to combat the escalation of severity and course of psoriasis and possibly psoriatic arthritis.
John Elflein. COVID-19 causes, recoveries, deaths, among most impacted countries as of May 22, 2020. Statista 2020.
Griffiths CEM, Van der Walt DM, Ashcroft DM, Flohr, Naldi L, Nijsten T, and Augustin M. Brit J Dermatol 2017;177(1):e4-e7.
Lionel Fry, Barbra S Baker. Triggering psoriasis: the role of infections and medications. Clinics in Dermatology. 2007;25:606-615.
Al Abadie MS, Kent GG, and Gawkrodger, The Relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. DJ. Brit J Dermatol 1994;130(2):199-203.
Jaymie Baliwag, Drew H Barnes and Andrew Johnston. Cytokines in Psoriasis. Cytokines. 2015; 73(2): 342-350.
Rajeev Patrick Das, Arun Kumar Jain, and V Ramesh. Current concepts in the pathogenesis of Psoriasis. India Journal of Dermatology. 2009;54(1):7-12.
Al Abadie MS, Senior HJ, Bleehen SS, and Gawkrodger DJ. Neuropeptides and general neuronal marker in psoriasis: an immunohistochemical study. Clin & Exper Dermatology 1995; 20(5): 348-389.
Saraceno R, Kleyn CE, Terenghi G, Griffiths CEM. The role of neuropeptides in psoriasis. Brit J Dermatol. 2006;155(5):876-882.
Belew PW, Wannamaker LW, Johnson D et al. Beta haemolytic streptococcal types associated with psoriasis In: Kimura K, Kotami S, Shiokawa Y editors. Recent advances in streptococci and streptococcal diseases. UK: Reeadbooks Ltd: 1985. P334.
Telfer N, Chalmers RJG, Whale K, et al. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992;128:39-42.
Tomi NS, Kranke B, and Aberer E. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, erythroderma and in healthy control subjects. J Am Acad Dermatol. 2005;53:67-72.
Farr PM, Krause LB, Marks JM et al. Responce of scalp psoriasis to oral ketoconazole. Lancet 1985;2:921-2.
Leung DYM, Walsh P, Giorna R, et al. A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol. 1993;100:225-8.
Moles JP, Tesniere A, Guilhou JJ. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis. Br J Dermatol. 2005;153:83-9.
Kanada KN, Schupp CW, Armstrong AW. Association between psoriasis and viral infections in the United states: Focusing on hepatitis B, hepatitis C, and human immunodeficiency virus. JEADV 2013;27:1312-1316.
Abel EA, Dicicco LM, Orenberg EK, et al. Druge in exacerbation of psoriasis. J Am Acad Dermatol 1986;15:1007-22.
De Socio G, Simonetti S, Stagni G. Clinical improvement of psoriasis in an AIDS patient effectively treated with combination antiretroviral therapy.
This work is licensed under a Creative Commons Attribution 4.0 International License.